Repligen
RGEN
439 hedge funds and large institutions have $9.07B invested in Repligen in 2023 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 162 increasing their positions, 157 reducing their positions, and 60 closing their positions.
17% more capital invested
Capital invested by funds: $7.74B → $9.07B (+$1.33B)
4.19% more ownership
Funds ownership: 98.18% → 102.38% (+4.2%)
9% more call options, than puts
Call options by funds: $36.9M | Put options by funds: $34M
3% more repeat investments, than reductions
Existing positions increased: 162 | Existing positions reduced: 157
7% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 60
2% less funds holding
Funds holding: 446 → 439 (-7)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$119M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$89.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$51M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$42.7M |
| 5 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$40M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$39.6M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$34.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$28.4M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$21M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$19.6M |
RGEN Hedge Fund Activity: Q3 2023 in Review
439 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q3 2023, worth a combined $9.07B — up 17% from $7.74B a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of RGEN and 56 opened new positions — a net loss of 4 holders — while 157 trimmed existing stakes and 162 added.
The largest buyer was Harding Loevner, opening a new position worth an estimated $119M. The largest seller was Fidelity Investments, cutting an estimated $39.6M.
- 439 institutional investors held Repligen (RGEN) as of Q3 2023, down from 446 in Q2 2023.
- Funds reported $9.07B of Repligen stock for Q3 2023, up 17% quarter-over-quarter.
- 56 funds opened new Repligen positions in Q3 2023 and 60 closed out, a net change of -4 holders.
- The largest Repligen buyer in Q3 2023 was Harding Loevner, an estimated $119M added.
- The largest Repligen seller in Q3 2023 was Fidelity Investments, an estimated $39.6M sold.
Based on aggregated 13F filings for Q3 2023.